{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:20:16Z","timestamp":1791249616244,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.urolonc.2013.06.008","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T09:30:58Z","timestamp":1379496658000},"page":"45.e23-45.e30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Predicting response to bacillus Calmette-Gu\u00e9rin (BCG) in patients with carcinoma in situ of the bladder"],"prefix":"10.1016","volume":"32","author":[{"given":"Rafael","family":"Nunez-Nateras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik P.","family":"Castle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl A.","family":"Protheroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolgay I.","family":"Ocal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin N.","family":"Ferrigni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei I.","family":"Ochkur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Xian","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas V.","family":"Colby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2013.06.008_bib1","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1505::AID-CNCR19>3.0.CO;2-3","article-title":"The National Cancer Database report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society","volume":"78","author":"Fleshner","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2013.06.008_bib2","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib3","unstructured":"Fast Stats: An interactive tool for access to seer cancer statistics. Surveillance Research Program National Cancer Institute. Fast Stats: \u3008http:\/\/seer.cancer.gov\/faststats\u3009; [accessed on 15.3.11]."},{"key":"10.1016\/j.urolonc.2013.06.008_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.urology.2005.06.135","article-title":"High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder","volume":"66","author":"Sylvester","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2013.06.008_bib5","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update","volume":"59","author":"Babjuk","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.juro.2007.08.122","article-title":"History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story","volume":"179","author":"Herr","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib7","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/S0022-5347(05)64994-4","article-title":"Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without maintenance","volume":"167","author":"Griffiths","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-5347(17)32741-6","article-title":"Durability of the tumor-free response for intravesical bacillus Calmette-Guerin therapy","volume":"152","author":"Nadler","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.eururo.2006.01.017","article-title":"Management of BCG failures in superficial bladder cancer: a review","volume":"49","author":"Witjes","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.eursup.2004.02.013","article-title":"Prognosis of T1 Grade 3 tumors: clinical factors","volume":"3","author":"Barmoshe","year":"2004","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.urolonc.2013.06.008_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.rmed.2003.12.003","article-title":"Analysis of local T lymphocyte subsets upon stimulation with intravesical BCG: a model to study tuberculosis immunity","volume":"98","author":"Ponticiello","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.urolonc.2013.06.008_bib12","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1128\/IAI.66.12.5743-5750.1998","article-title":"Mycobacterial dose defines the Th1\/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route","volume":"66","author":"Power","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.urolonc.2013.06.008_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2222.2010.03484.x","article-title":"Eosinophils in health and disease: the liar hypothesis","volume":"40","author":"Lee","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.urolonc.2013.06.008_bib14","series-title":"Eosinophils in Health and Disease","first-page":"654","author":"Lee","year":"2012"},{"key":"10.1016\/j.urolonc.2013.06.008_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2011.09.026","article-title":"Markers predicting response to bacillus Calmette-Gu\u00e9rin immunotherapy in high-risk bladder cancer patients: a systematic review","volume":"61","author":"Zuiverloon","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cgh.2009.03.022","article-title":"A novel histological scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis","volume":"7","author":"Protheroe","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib17","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/MCB.21.8.2716-2725.2001","article-title":"Structure and specificity of GATA proteins in Th2 development","volume":"21","author":"Ranganath","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, t-bet, directs th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2013.06.008_bib19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","article-title":"Intraclass correlations: uses in assessing rater reliability","volume":"86","author":"Shrout","year":"1979","journal-title":"Psychol Bull"},{"key":"10.1016\/j.urolonc.2013.06.008_bib20","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib21","doi-asserted-by":"crossref","first-page":"232609","DOI":"10.1155\/2012\/232609","article-title":"Predictive biomarkers of bacillus Calmette-Guerin immunotherapy response in bladder cancer: where are we now?","volume":"2012","author":"Lima","year":"2012","journal-title":"Adv Urol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.urolonc.2007.11.031","article-title":"Role of neutrophils in BCG immunotherapy for bladder cancer","volume":"26","author":"Simons","year":"2008","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib23","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.juro.2008.11.090","article-title":"Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Gu\u00e9rin instillation","volume":"181","author":"Takayama","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.urology.2009.02.053","article-title":"Efficacy of bacille Calmette-Gu\u00e9rin immunotherapy predicted by expression of antigen-presenting molecules and chemokines","volume":"74","author":"Videira","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2013.06.008_bib25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-5347(05)65469-9","article-title":"Prognostic value of a T helper 1 urinary cytokine response after intravesical bacillus Calmette-Gu\u00e9rin treatment for superficial bladder cancer","volume":"167","author":"Saint","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00262-003-0384-9","article-title":"Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu\u00e9rin immunotherapy for carcinoma in situ of the bladder","volume":"52","author":"Watanabe","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.urolonc.2013.06.008_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0090-4295(01)01551-5","article-title":"Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Gu\u00e9rin therapy","volume":"59","author":"Peyromaure","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2013.06.008_bib28","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0022-5347(01)61770-1","article-title":"Correlation and prognostic significance of p53, p21WAF1\/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Gu\u00e9rin intravesical therapy","volume":"161","author":"Zlotta","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.06.008_bib29","unstructured":"\u3008http:\/\/www.fda.gov\/BiologicsBloodVaccines\/CellularGeneTherapy\/Products\/ ApprovedProducts\/ucm310645.htm\u3009."},{"key":"10.1016\/j.urolonc.2013.06.008_bib30","unstructured":"\u3008http:\/\/www.auanet.org\/eforms\/hpbrief\/view.cfm?i=1160&a=2764\u3009."}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913002573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913002573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:03:55Z","timestamp":1761041035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143913002573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1078143913002573"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.06.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting response to bacillus Calmette-Gu\u00e9rin (BCG) in patients with carcinoma in situ of the bladder","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}